Страна: США
мова: англійська
Джерело: NLM (National Library of Medicine)
AMLODIPINE BESYLATE (UNII: 864V2Q084H) (AMLODIPINE - UNII:1J444QC288)
State of Florida DOH Central Pharmacy
AMLODIPINE BESYLATE
AMLODIPINE 10 mg
ORAL
PRESCRIPTION DRUG
Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. Amlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal agents. Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal drugs. In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, amlodipine besylate tablets are indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure. Amlodipine is contraindicated in patients with known sensitivity to amlodipine.
Amlodipine besylate tablets, 2.5 mg are white to off-white colored, diamond-shaped, flat-faced, beveled-edge tablets, debossed with 568 on one side and plain on the other side: Amlodipine besylate tablets, 5 mg are white to off-white colored, octagonal, flat-faced, beveled-edge tablets, debossed with 569 on one side and plain on the other side: Amlodipine besylate tablets, 10 mg are white to off-white colored, circular, flat-faced, beveled-edge tablets, debossed with 570 on one side and plain on the other side: They are supplied by State of Florida DOH Central Pharmacy as follows: Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Protect from light and moisture Viagra ® is a registered trademark of Pfizer. Maalox ® is a registered trademark of Novartis. Manufactured by: Caraco Pharmaceutical Laboratories, Ltd. 1150 Elijah McCoy Drive Detroit, MI 48202 This Product was Repackaged By: State of Florida DOH Central Pharmacy 104-2 Hamilton Park Drive Tallahassee, FL 32304 United States
Abbreviated New Drug Application
AMLODIPINE - AMLODIPINE BESYLATE TABLET STATE OF FLORIDA DOH CENTRAL PHARMACY ---------- DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzene-sulphonate. Its molecular formula is C H CIN O •C H O S, and its structural formula is: Amlodipine besylate is a white crystalline powder with a molecular weight of 567.1. It is slightly soluble in water and sparingly soluble in ethanol. Amlodipine besylate tablets are formulated as white tablets equivalent to 2.5 mg, 5 mg or 10 mg of amlodipine for oral administration. In addition to the active ingredient, amlodipine besylate, each tablet contains the following Inactive Ingredients: dibasic calcium phosphate (anhydrous), butylated hydroxytoluene, microcrystalline cellulose, sodium starch glycolate, magnesium stearate. CLINICAL PHARMACOLOGY MECHANISM OF ACTION Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Negative inotropic effects can be detected _in vitro _but such effects have not been seen in intact animals at therapeutic doses. Serum calcium concentration is not affected by amlodipine. Within the physiologic pH range, amlodipine is an ionized compound (pK =8.6), and its kinetic interaction with the calcium channel receptor is characterized by a gra Прочитайте повний документ